glp-1 muscle mass A Hidden Consequence of GLP-1s: Loss and Why It Matters More Than You Think - Bay Life GLP-1 Weight Loss Risks: Muscle

GLP-1 receptor agonists like semaglutide require special evaluation and approval before use

Why This Guide Works: Our guide addresses the unique challenges of GLP-1 medication users, including reduced appetite, slower digestion, and the need for adequate nutrients despite eating less

The Phase 3 ATTAIN-1 trial had good results that led to this approval, but not all positive: 12.4% average weight loss (27.3 lbs) at highest dose Lower than the 15-20% weight loss seen with injectables Wegovy and Zepbound Nearly 1/4 of participants on the highest dose reported vomiting Vomiting rates are much higher than injectable GLP-1s However, there is likely a niche for Foundayo (along with the pill version of Wegovy) due to convenience: No refrigeration requirements or injection site reactions Eliminates barriers for patients avoiding injectables due to stigma, needle aversion, or storage constraints It's possible we could see this as a "maintenance" therapy after an initial injectable course

Start soup on stovetop if making

Frequently Asked Questions Can you drink protein shakes while taking GLP-1 medications